Loading…
Stenttherapie bei diabeteskranken Koronarpatienten
When bare-metal stents are used, diabetic patients with coronary artery disease have a poorer prognosis than non-diabetic patients after coronary interventions. In clinical studies, it could be demonstrated that the disadvantage for diabetic patients is not present when drug-eluting stents are used....
Saved in:
Published in: | Clinical research in cardiology 2006-01, Vol.95, p.i27 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | ger |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | When bare-metal stents are used, diabetic patients with coronary artery disease have a poorer prognosis than non-diabetic patients after coronary interventions. In clinical studies, it could be demonstrated that the disadvantage for diabetic patients is not present when drug-eluting stents are used. Today, two types of drug-eluting stents are clinically used: the sirolimus-eluting stent (Cypher(TM)) and the paclitaxel-eluting stent (Taxus(TM)). Even the high risk group of patients with in-stent stenosis can be efficiently treated with drugeluting stents.[PUBLICATION ABSTRACT] |
---|---|
ISSN: | 1861-0684 1861-0692 |
DOI: | 10.1007/s00392-006-1111-2 |